KIRAN THAPALIYA1, Sonya Marshall-Gradisnik1, Markus Barth2, Natalie Eaton-Fitch1, and Leighton Barnden1
1Griffith University, Gold coast, Australia, 2The University of Queensland, Brisbane, Australia
Synopsis
Keywords: Neurodegeneration, Brain
COVID -19
caused by the novel Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) has infected more than 600 million and caused the deaths of over
six million people worldwide. The
majority of the infected patients do not recover fully from the COVID-19
infections and develop post-COVID conditions also known as long-COVID has similar
symptoms compared to Myalgic Encephalomyelitis/Chronic fatigue syndrome.
In this study, we evaluated the volumetric changes in the brainstem regions in
ME/CFS, long-COVID patients compared to healthy controls. Our study showed that brainstem volumes higher
in ME/CFS and long-COVID patients compared to healthy controls.
Introduction
Myalgic Encephalomyelitis
(ME) also known as Chronic fatigue
syndrome (CFS) (ME/CFS) is a complex illness characterised by profound fatigue
for more than 6 months that impairs cognitive and motor dysfunction, and
unrefreshing sleep1 that are similar
to the symptoms
in the long-COVID patients2.
Magnetic resonance
imaging (MRI) is non-invasive, can detect subtle changes in brain structure and
has been used to study brain dysfunction in ME/CFS and COVID patients. Recently,
an ME/CFS study demonstrated increased hippocampal subfield volumes3 and reduced caudal
middle frontal volume and precuneus thickness4. An MRI study in
COVID-19 patients showed reduced grey matter thickness in the para-hippocampal
gyrus, anterior cingulate cortex, and temporal lobe5.
The brainstem region regulates
respiratory, cardiovascular,
gastrointestinal, and neurological processes which are the most common symptoms
of ME/CFS and long-COVID patients. Therefore, the specific aims of this study was to quantify
volumes of brainstem subregions and the whole brainstem in ME/CFS and
long-COVID and compare them to healthy controls. Methods
The
study was approved by the local human ethics (HREC/2019/QGC/56469) committee of
the
Gold Coast University Hospital and written informed consent was obtained from
all individuals.
MRI
was performed on a 7 T whole-body
MRI research scanner (Siemens Healthcare, Erlangen, Germany) with a 32-channel
head coil (Nova Medical Wilmington, USA). We acquired T1-weighted data using a Magnetisation
prepared 2 rapid acquisition gradient echo sequence (MP2RAGE) as in7. In brief, MP2RAGE
data were acquired sagittally using the following parameters: repetition time
(TR) = 4300 ms, echo time (TE) = 2.45 ms, first inversion time (TI1) = 840 ms,
TI2 = 2370 ms, first flip angle (FA1) = 5o, FA2 = 6o and
resolution = 0.75 mm3 with matrix size = 256 × 300 × 320.
MP2RAGE
data were processed similarly to our previous publications5 using FreeSurfer
version 7.1.1 8 (https://surfer.nmr.mgh.harvard.edu/).
Detailed information about the pipeline can be found at (https://surfer.nmr.mgh.harvard.edu/fswiki/recon-all)
Brainstem subregions were
segmented using the FreeSurfer 7.1.1 brainstem module8 as
shown in Figure 1. Using this module, the brainstem was segmented into the midbrain,
pons, superior cerebellar peduncle (SCP), and medulla oblongata. Brainstem
subregions for all participants were visually checked for distortion-free
segmentation.
Multivariate general linear model (GLM) statistical analysis was
performed to test brainstem subregions and whole brainstem volume differences
between ME/CFS, long-COVID patients, and HC using SPSS version 28.Results
The brainstem subregion volumes were larger in
ME/CFS patients compared to HC (see Table 1). After adjusting for multiple
comparisons, volumes remained significantly larger in the pons
(p<0.012) and whole brainstem region (p<0.03) (see Table 1).
In long-COVID patients,
after adjusting for multiple comparisons, we observed significantly larger
volumes in the pons (p=0.009), SCP (p=0.027), and whole brainstem
regions (p=0.014). Interestingly, no significant volumetric differences were obtained between ME/CFS and long-COVID patients.Discussion
Our study found significantly larger
volumes for whole brainstem, pons, and SCP in ME/CFS and long-COVID patients. The brainstem
contains the reticular activation system (RAS) . RAS neurons influence cortical
function via two different pathways9. Brainstem nuclei constitute a circuit that
controls both cortical arousal levels (cognition, wake / sleep, pain,
respiration) and gait selection (eg walking or running)10. Therefore,
structural changes in the brainstem of ME/CFS and long-COVID patients could
result in severe and varied deficits in brain functionConclusion
In
this pilot study, volumetric differences in brainstem regions were detected in
ME/CFS and long-COVID relative to HC. Interestingly, we did not find any
differences between ME/CFS and long-COVID in the whole brainstem and its
subregion volumes. Acknowledgements
This research is
funded by ME Research UK (MERUK, https://www.meresearch.org.uk/ ). Other funding bodies include: the Stafford Fox Medical Research
Foundation (489798), the National Health and Medical Research Council
(1199502), McCusker Charitable Foundation (49979), Ian and Talei Stewart,
Buxton Foundation (4676), Henty Community (4879), Henty Lions Club (4880),
Mason Foundation (47107), Mr Douglas Stutt, Blake Beckett Trust Foundation
(4579), Alison Hunter Memorial Foundation (4570), and the Change for ME Charity
(4575). We are also thankful to Ms. Tania Manning and Kay Schwarz for recruiting participants for this study, radiographers (Nicole Atcheson, Aiman Al-Najjar, Jillian Richardson, and Sarah Daniel) at the Centre for Advanced Imaging, The University of Queensland for helping us to acquire MRI data and all the patients and healthy controls who donated their time and effort to participate in this study. The authors
acknowledge the facilities of the National Image Facility at the Centre for
Advanced Imaging.References
1. Fukuda
K. The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and
Study. Ann Intern Med. 1994;121(12):953.
doi:10.7326/0003-4819-121-12-199412150-00009
2. Komaroff
AL, Bateman L. Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue
Syndrome? Frontiers in Medicine. 2021;7. Accessed September 29, 2022.
https://www.frontiersin.org/articles/10.3389/fmed.2020.606824
3. Thapaliya
K, Staines D, Marshall-Gradisnik S, Su J, Barnden L. Volumetric differences in
hippocampal subfields and associations with clinical measures in myalgic
encephalomyelitis/chronic fatigue syndrome. J Neurosci Res. Published
online March 31, 2022. doi:10.1002/jnr.25048
4. Thapaliya
K, Marshall-Gradisnik S, Staines D, Su J, Barnden L. Alteration of Cortical
Volume and Thickness in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Frontiers
in Neuroscience. 2022;16. Accessed May 9, 2022.
https://www.frontiersin.org/article/10.3389/fnins.2022.848730
5. Douaud
G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in
brain structure in UK Biobank. Nature. 2022;604(7907):697-707.
doi:10.1038/s41586-022-04569-5
6. Thapaliya
K, Urriola J, Barth M, Reutens DC, Bollmann S, Vegh V. 7T GRE-MRI signal
compartments are sensitive to dysplastic tissue in focal epilepsy. Magnetic
resonance imaging. 2019;61:1-8.
7. Fischl
B. FreeSurfer. NeuroImage. 2012;62(2):774-781.
doi:10.1016/j.neuroimage.2012.01.021
8. Iglesias JE, Van Leemput K, Bhatt P, et al.
Bayesian segmentation of brainstem structures in MRI. Neuroimage.
2015;113:184-195. doi:10.1016/j.neuroimage.2015.02.065
9. Saper
CB, Fuller PM. Wake-sleep circuitry: an overview. Curr Opin Neurobiol.
2017;44:186-192. doi:10.1016/j.conb.2017.03.021
10. Benarroch
EE. Brainstem integration of arousal, sleep, cardiovascular, and respiratory
control. Neurology. 2018;91(21):958-966. doi:10.1212/WNL.0000000000006537